[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627209":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":36,"locations":42,"responsibleParty":59,"collaborators":26,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":26,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":26,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":83,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Kayseri City Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Conox","EXPERIMENTAL","Induction: Propofol 2-3 mg\u002Fkg, fentanyl 2 µg\u002Fkg, and rocuronium 0.6 mg\u002Fkg. Maintenance: Sevoflurane (1.0-1.3 MAC) and remifentanil infusion at 0.1 µg\u002Fkg\u002Fh.\n\nIn the Conox group, anesthetic and analgesic titration will be performed targeting qCON values of 40-60 and qNOX values of 30-60.",[13],"Device: Connox EEG Monitoring",{"label":15,"type":16,"description":17,"interventionNames":18},"control","ACTIVE_COMPARATOR","Induction: Propofol 2-3 mg\u002Fkg, fentanyl 2 µg\u002Fkg, and rocuronium 0.6 mg\u002Fkg. Maintenance: Sevoflurane (1.0-1.3 MAC) and remifentanil infusion at 0.1 µg\u002Fkg\u002Fh.In the control group, conventional titration will be guided by heart rate and mean arterial pressure changes.\n\nTotal intraoperative opioid consumption, recovery time, extubation time, agitation scores, and pain scores will be recorded.",[19],"Other: standard anesthesia management",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Connox EEG Monitoring","Conox EEG monitor will be applied intraoperatively. Anesthetic and opioid titration will be guided by qCON values between 40-60 and qNOX values between 30-60. Opioid administration will be adjusted according to qNOX levels in addition to standard clinical monitoring.",[9],null,{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":26},"OTHER","standard anesthesia management","Standard anesthesia management will be performed according to routine clinical practice. Opioid titration will be guided by conventional hemodynamic parameters including heart rate and mean arterial pressure. No EEG-based monitoring will be used for analgesia titration.",[15],[33],{"name":34,"affiliation":5,"role":35},"çiğdem ünal kantekin, MD","PRINCIPAL_INVESTIGATOR",[37],{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},"Çiğdem Ünal Kantekin, MD","CONTACT","+905054433056","drcgdm@gmail.com",[43],{"facility":5,"status":44,"city":45,"state":45,"zip":46,"country":47,"countryCode":26,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Kayseri","38080","Turkey (Türkiye)",{"type":49,"coordinates":50},"Point",[51,52],35.48528,38.73222,{"lat":52,"lon":51},[55],{"name":56,"role":39,"phone":57,"phoneExt":26,"email":58},"Çiğdem Ünal Kantekin","5054433056","drcgdm@hotmail.com",{"type":35,"investigatorFullName":56,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Associate Professor of Anesthesiology","100627209","qconqnox-guided-anesthesia-in-patients-undergoing-thyroidectomy-surgery-100627209",false,"NCT07445659","qCON\u002FqNOX-Guided Anesthesia in Patients Undergoing Thyroidectomy Surgery","The Effect of qCON\u002FqNOX-Guided Anesthesia Using the Conox Monitor on Clinical Outcomes in Patients Undergoing Thyroidectomy Surgery","Inclusion Criteria:\n\n* Patients aged 18-70 years\n* Thyroidectomy cases with ASA physical status I-II\n* Patients who have provided written informed consent\n\nExclusion Criteria:\n\n* Skin lesions preventing EEG electrode placement\n* Neurological disorders (e.g., epilepsy)\n* Anticipated difficult airway",true,"ALL","18 Years","70 Years",{"count":73,"type":74},90,"ESTIMATED","INTERVENTIONAL",[77],"NA","The aim of this study is to evaluate the effect of using the non-invasive Conox monitor on intraoperative opioid consumption. Additionally, the study aims to assess the impact of Conox monitoring on recovery time, postoperative agitation rate, and pain scores, and to investigate the correlation between qCON and qNOX values and conventional hemodynamic parameters.",[80,81,82],"Thyroid Surgeries","Intraoperative Analgesic Use","Anesthesia Depth Monitoring",[84,85,86,87,88],"thyroid surgery","intraoperative opioid consumption","anesthesia depth monitoring","qCON","qNOX","2026-04-16",{"date":91,"type":92},"2026-04-20","ACTUAL",{"date":94,"type":92},"2026-04-10",{"date":96,"type":74},"2026-06-30",{"name":5,"class":6},1]